Company: TVRD
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111289
Chunk: 26

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 4
Chunk 26
---
Item 4. Mine Safety Disclosures

​

Not applicable.

​

Item 5. Other Information

​

 During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.

​

Item 6. Exhibits.

​

​​​​​​​​​​​​​Incorporated by ReferenceExhibitNo.​Description of Exhibit​Form​File No.​Exhibit No.​Date Filed​​​​​​​​​​​2.1‡    Agreement and Plan of Merger and Reorganization, dated as of December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc.    8-K    001-36279    2.1    December 18, 2024​​​​​​​​​​​3.1​Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​February 7, 2014​​​​​​​​​​​3.2​Amended and Restated Bylaws.​10-Q​001-36279​3.2​November 14, 2024​​​​​​​​​​​3.3​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​June 7, 2024​​​​​​​​​​​3.4​Certificate of Amendment to Amended and Restated Certificate of Incorporation.​8-K​001-36279​3.1​December 30, 2024​​​​​​​​​​​3.5​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Stock Split Amendment).​8-K​001-36279​3.1​April 15, 2025​​​​​​​​​​​3.6​Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cara Therapeutics, Inc., dated April 15, 2025 (Authorized Shares Amendment).​8-K​001-362